Overview
Effect of Intranasal Oxytocin on Dysphagia in Children and Adolescents With Prader-Willi Syndrome
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2024-12-31
2024-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
This phase 3 is designed to test the effectiness of intranasal Oxytocin on Prader Willi Syndrome (PWS). This is a prospective, multicentre, randomised, double-blind, Phase 3 clinical study planned to include around 36 PWS patients aged 2-17 years and 5 months.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
University Hospital, ToulouseTreatments:
Oxytocin
Criteria
Inclusion Criteria:1. Male or female patients between 2 years and 17 years and 5 months at inclusion.
2. Genetically confirmed diagnosis of PWS.
3. Parents (or legal representative) have signed the informed consent form and are
willing to comply with all study procedures.
Exclusion Criteria:
1. A history of hypersensitivity to the study drug or drugs with similar chemical
structures, to excipients of the product, or to latex;
2. Intolerance of intranasal administrations (including when due to a major behavioural
problem);
3. Hyponatremia (clinically relevant at the discretion of the investigator);
4. Hypokalaemia (clinically relevant at the discretion of the investigator);
5. Prolongation of the QT interval and/or family history of prolongation of the QT
interval;
6. Concomitant treatment prolonging the QT interval;
7. Start of GH treatment within the last 4 weeks before inclusion;
8. History of abnormal electrocardiogram (ECG) (validated by a cardiologist);
9. Pregnant girls; (for girls with childbearing potential who do not have contraception
and are sexually active, a negative pregnancy test will be required)
10. Patient with clinical signs in the context of contact with SARs-COV2 infected person.
11. Patient included in another study protocol on a medicinal product within the last 6
months;
12. Administrative problems:
1. Inability to give parents (or legal representatives) expert medical information;
2. No coverage by a social security regime.